Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 5, 2020, after the close
10-Q filed Nov 5, 2020, 36 days after period end · 0000320017-20-000110
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$5.33M | -$4.90M | -$3.55M | -$3.55M |
| EPS Diluted | -$0.29 | -$0.47 | -$0.36 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
